Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
100.61
+2.31 (2.35%)
At close: Sep 10, 2026, 4:00 PM EDT
101.00
+0.39 (0.39%)
After-hours: Sep 10, 2026, 7:30 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.53 billion as of September 10, 2026. Its market cap has increased by 67.38% in one year.
Market Cap
6.53B
Enterprise Value
6.86B
1-Year Change
67.38%
Ranking
Category
Stock Price
$100.61
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.53B, an increase of 2,097.93%. That is a compound annual growth rate of 54.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 6.53B | 60.02% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 7.05B |
| Rhythm Pharmaceuticals | 7.04B |
| Scholar Rock Holding | 6.96B |
| CG Oncology | 6.46B |
| Oruka Therapeutics | 6.30B |
| Travere Therapeutics | 6.26B |
| Cogent Biosciences | 6.17B |
| Dianthus Therapeutics | 6.15B |